Attivita regolatoria europea ed uso 'off-label' dei farmaci in eta pediatrica

Translated title of the contribution: Drug approval processes and off-label use of medications for children

P. Impicciatore, S. Conroy, I. Choonara, M. Bonati

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of licensing is to control the manufacture, provision, promotion and supply of medicines. To fulfil that purpose medicines are examined by regulatory agencies for safety, efficacy and quality. Many new medicines and the vast majority of older medications have been approved without labelling for paediatric use because research for establishing their safety and efficacy in children has not been carried out. The new European guidance on clinical investigation of medicinal products in children states that children should not be given medicines which have not been evaluated for use in that age group. The European legislation, however, makes provision for physicians to use medicines that do not have a marketing authorisation (unlicensed) and for purposes other than those stated in the marketing authorisation (off-label). Consequently, many medicines are prescribed for children without specific knowledge of the dosage, metabolism and potential side effects. The absence of appropriate usage information of the product in paediatric patients prevents health professionals to administer the drug in a manner that maximises safety and optimises treatment efficacy. This longstanding underprivileged position of children in respect of medicines could be improved by the new European drug registration system supported by the European Medicines Evaluation Agency. This paper evaluates the current status with regard to labelling for paediatric use of new medicines granted a pan-European marketing authorisation. It also describes current initiatives in Europe to facilitate and encourage drug research in children in order to achieve the necessary drug labelling to reduce unapproved uses of medication in children.

Translated title of the contributionDrug approval processes and off-label use of medications for children
Original languageItalian
Pages (from-to)232-236
Number of pages5
JournalGiornale Italiano di Farmacia Clinica
Volume12
Issue number4
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Drug approval processes and off-label use of medications for children'. Together they form a unique fingerprint.

Cite this